These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Stark M; Hayward N Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583 [TBL] [Abstract][Full Text] [Related]
4. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization. Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166 [TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996 [TBL] [Abstract][Full Text] [Related]
6. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines. Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919 [TBL] [Abstract][Full Text] [Related]
7. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines. Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710 [TBL] [Abstract][Full Text] [Related]
8. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Bastian BC; LeBoit PE; Hamm H; Bröcker EB; Pinkel D Cancer Res; 1998 May; 58(10):2170-5. PubMed ID: 9605762 [TBL] [Abstract][Full Text] [Related]
9. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor. Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329 [TBL] [Abstract][Full Text] [Related]
10. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis]. Tagawa H Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530 [TBL] [Abstract][Full Text] [Related]
13. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531 [TBL] [Abstract][Full Text] [Related]
15. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474 [TBL] [Abstract][Full Text] [Related]
16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447 [TBL] [Abstract][Full Text] [Related]
18. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187 [TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824 [TBL] [Abstract][Full Text] [Related]
20. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Namiki T; Yanagawa S; Izumo T; Ishikawa M; Tachibana M; Kawakami Y; Yokozeki H; Nishioka K; Kaneko Y Cancer Genet Cytogenet; 2005 Feb; 157(1):1-11. PubMed ID: 15676140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]